Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 151,111 $ 130,572
Short-term restricted cash 105 105
Short-term investments 19,051 0
Accounts receivable, net 125,693 119,724
Inventory 139,041 131,703
Prepaid expenses and other current assets 19,575 22,000
Total current assets 454,576 404,104
Long-term restricted cash 1,037 1,061
Property and equipment, net 60,022 60,924
Leased right-of-use assets 32,919 27,269
Intangible assets, net 140,153 152,540
Goodwill 306,713 306,668
Deferred tax assets 82,326 89,168
Other long-term assets 21,381 8,650
Total assets 1,099,127 1,050,384
Current liabilities:    
Accounts payable 60,214 52,976
Accrued price protection liability 68,349 40,509
Accrued expenses and other current liabilities 75,553 57,268
Accrued compensation 30,679 56,642
Total current liabilities 234,795 207,395
Long-term lease liabilities 30,208 24,640
Long-term debt 286,298 306,153
Other long-term liabilities 19,980 22,998
Total liabilities 571,281 561,186
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 77,375 shares issued and outstanding at March 31, 2022 and 76,778 shares issued and outstanding December 31, 2021 8 8
Additional paid-in capital 663,622 657,485
Accumulated other comprehensive income 1,050 2,125
Accumulated deficit (136,834) (170,420)
Total stockholders’ equity 527,846 489,198
Total liabilities and stockholders’ equity $ 1,099,127 $ 1,050,384